Aspiriant LLC’s Costco COST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.93M | Sell |
1,933
-286
| -13% | -$279K | 0.05% | 113 |
|
|
2025
Q4 | $1.91M | Buy |
2,219
+188
| +9% | +$170K | 0.06% | 114 |
|
|
2025
Q3 | $1.88M | Sell |
2,031
-180
| -8% | -$173K | 0.06% | 105 |
|
|
2025
Q2 | $2.19M | Buy |
2,211
+80
| +4% | +$79.5K | 0.07% | 96 |
|
|
2025
Q1 | $2.02M | Buy |
2,131
+117
| +6% | +$114K | 0.07% | 95 |
|
|
2024
Q4 | $1.85M | Buy |
2,014
+32
| +2% | +$29.7K | 0.07% | 100 |
|
|
2024
Q3 | $1.76M | Sell |
1,982
-128
| -6% | -$111K | 0.07% | 101 |
|
|
2024
Q2 | $1.79M | Sell |
2,110
-217
| -9% | -$169K | 0.07% | 96 |
|
|
2024
Q1 | $1.7M | Buy |
2,327
+134
| +6% | +$95.7K | 0.07% | 104 |
|
|
2023
Q4 | $1.45M | Buy |
2,193
+20
| +0.9% | +$11.9K | 0.07% | 112 |
|
|
2023
Q3 | $1.23M | Buy |
2,173
+128
| +6% | +$70.7K | 0.06% | 119 |
|
|
2023
Q2 | $1.1M | Sell |
2,045
-48
| -2% | -$24.3K | 0.06% | 126 |
|
|
2023
Q1 | $1.04M | Buy |
2,093
+106
| +5% | +$52K | 0.05% | 131 |
|
|
2022
Q4 | $907K | Buy |
1,987
+346
| +21% | +$169K | 0.05% | 138 |
|
|
2022
Q3 | $775K | Sell |
1,641
-2
| -0.1% | -$1.04K | 0.04% | 138 |
|
|
2022
Q2 | $787K | Sell |
1,643
-16
| -1% | -$8.12K | 0.04% | 139 |
|
|
2022
Q1 | $956K | Sell |
1,659
-25
| -1% | -$13.1K | 0.05% | 135 |
|
|
2021
Q4 | $956K | Buy |
1,684
+665
| +65% | +$341K | 0.05% | 141 |
|
|
2021
Q3 | $458K | Sell |
1,019
-8
| -0.8% | -$3.52K | 0.03% | 165 |
|
|
2021
Q2 | $408K | Buy |
1,027
+29
| +3% | +$11K | 0.02% | 172 |
|
|
2021
Q1 | $352K | Buy |
998
+158
| +19% | +$55K | 0.02% | 165 |
|
|
2020
Q4 | $317K | Buy |
840
+45
| +6% | +$16.8K | 0.02% | 170 |
|
|
2020
Q3 | $283K | Buy |
795
+8
| +1% | +$2.69K | 0.02% | 185 |
|
|
2020
Q2 | $238K | Sell |
787
-150
| -16% | -$45.6K | 0.02% | 168 |
|
|
2020
Q1 | $267K | Sell |
937
-12
| -1% | -$3.64K | 0.03% | 165 |
|
|
2019
Q4 | $278K | Buy |
949
+17
| +2% | +$5.05K | 0.03% | 176 |
|
|
2019
Q3 | $269K | Sell |
932
-241
| -21% | -$67.8K | 0.02% | 187 |
|
|
2019
Q2 | $310K | Sell |
1,173
-67
| -5% | -$16.7K | 0.03% | 175 |
|
|
2019
Q1 | $301K | Sell |
1,240
-236
| -16% | -$51.6K | 0.02% | 183 |
|
|
2018
Q4 | $301K | Buy |
1,476
+5
| +0.3% | +$1.12K | 0.02% | 184 |
|
|
2018
Q3 | $346K | Buy |
1,471
+100
| +7% | +$22.5K | 0.03% | 184 |
|
|
2018
Q2 | $287K | Sell |
1,371
-168
| -11% | -$33.2K | 0.02% | 205 |
|
|
2018
Q1 | $290K | Buy |
+1,539
| New | +$290K | 0.03% | 196 |
|
|
2017
Q4 | – | Sell |
-2,045
| Closed | -$336K | – | 100 |
|
|
2017
Q3 | $336K | Sell |
2,045
-7,663
| -79% | -$1.2M | 0.03% | 156 |
|
|
2017
Q2 | $1.55M | Buy |
9,708
+302
| +3% | +$52K | 0.14% | 86 |
|
|
2017
Q1 | $1.58M | Buy |
9,406
+37
| +0.4% | +$6.2K | 0.13% | 95 |
|
|
2016
Q4 | $1.5M | Buy |
9,369
+38
| +0.4% | +$5.8K | 0.14% | 83 |
|
|
2016
Q3 | $1.42M | Buy |
9,331
+190
| +2% | +$30.7K | 0.14% | 85 |
|
|
2016
Q2 | $1.25M | Buy |
9,141
+366
| +4% | +$55.4K | 0.12% | 97 |
|
|
2016
Q1 | $1.38M | Buy |
+8,775
| New | +$1.33M | 0.13% | 87 |
|
Other funds holding COST
VCM
VPM
DAM
Aspiriant LLC's COST Position: Q1 2026 in Review
Aspiriant LLC reduced its Costco (COST) stake by 13% in Q1 2026, selling an estimated $279K and leaving 1,933 shares worth $1.93M. The position accounts for 0.05% of the portfolio, ranked #113.
Aspiriant LLC first reported a position in COST in Q1 2016 and has held it in 40 quarters since. The position peaked at $2.19M in Q2 2025. 4,236 funds tracked by Wall St. Rank hold COST as of Q1 2026.
- Aspiriant LLC held 1,933 shares of Costco worth $1.93M as of Q1 2026.
- Aspiriant LLC sold 286 Costco shares in Q1 2026, an estimated $279K.
- Costco made up 0.05% of Aspiriant LLC's portfolio in Q1 2026, its #113 holding.
- Aspiriant LLC first reported a position in Costco in Q1 2016 and has held it in 40 quarters since.
- Aspiriant LLC's Costco position peaked at $2.19M in Q2 2025.
- 4,236 funds tracked by Wall St. Rank held Costco as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.